2003 - Member of the European Academy of Sciences
Henri Rochefort mainly investigates Internal medicine, Endocrinology, Cathepsin D, Cancer cell and Cell culture. His study brings together the fields of Glycoprotein and Internal medicine. Henri Rochefort has included themes like Receptor, Epidermal growth factor, Growth factor and Estrogen receptor in his Endocrinology study.
His Estrogen receptor research is multidisciplinary, incorporating perspectives in Tamoxifen and Cytosol. Henri Rochefort has researched Cathepsin D in several fields, including Cancer research, Cathepsin, Transfection, Molecular biology and Metastasis. The Cancer cell study combines topics in areas such as Extracellular, Biochemistry, Cell growth, Matrigel and Growth factor receptor.
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Estrogen receptor, Estrogen and Cathepsin D. His research in Internal medicine intersects with topics in Cancer research and Oncology. His Endocrinology research is multidisciplinary, incorporating elements of Cell culture, Progesterone receptor, Mammary gland and Androgen receptor.
His studies deal with areas such as Tamoxifen and Cytosol as well as Estrogen receptor. Henri Rochefort works mostly in the field of Estrogen, limiting it down to topics relating to Growth factor and, in certain cases, Epidermal growth factor. The concepts of his Cathepsin D study are interwoven with issues in Cathepsin, Secretion, Transfection, Molecular biology and Metastasis.
His scientific interests lie mostly in Estrogen receptor, Internal medicine, Endocrinology, Cancer research and Breast cancer. Henri Rochefort interconnects Immunohistochemistry, Cell culture and Estrogen in the investigation of issues within Estrogen receptor. His Endocrinology research is multidisciplinary, incorporating perspectives in Cancer cell, Receptor and Motility.
He combines subjects such as Cell surface receptor, Cathepsin, Cell growth and Transfection with his study of Cancer cell. His Cancer research study combines topics from a wide range of disciplines, such as Cathepsin D, Ovarian cancer, Metastasis, Tumor progression and Growth factor receptor. His work deals with themes such as Carcinogenesis and Oncology, which intersect with Breast cancer.
Internal medicine, Cancer cell, Estrogen receptor, Endocrinology and Cathepsin D are his primary areas of study. His Cancer cell research integrates issues from Cathepsin and Cell biology. His study in Estrogen receptor is interdisciplinary in nature, drawing from both Ovarian cancer, Estrogen, Mammary gland and Oncology.
The various areas that he examines in his Estrogen study include Cell culture, Fibronectin, Extracellular matrix, Fibulin and Motility. His Cathepsin D research incorporates elements of Cancer, Breast cancer, Metastasis, Cancer research and Cell growth. The study incorporates disciplines such as Cell surface receptor and Transfection in addition to Cell growth.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Decreased Expression of Estrogen Receptor β Protein in Proliferative Preinvasive Mammary Tumors
Pascal Roger;Majida Esslimani Sahla;Sari Mäkelä;Jan Åke Gustafsson.
Cancer Research (2001)
A secreted glycoprotein induced by estrogen in human breast cancer cell lines
Bruce Westley;Henri Rochefort.
Cell (1980)
Tamoxifen and Metabolites in MCF7 Cells: Correlation between Binding to Estrogen Receptor and Inhibition of Cell Growth
Ericque Coezy;Jean-Louis Borgna;Henri Rochefort.
Cancer Research (1982)
Steroid hormone receptors.
Etienne-Emile Baulieu;Michel Atger;Martin Best-Belpomme;Pierre Corvol.
Vitamins and Hormones Series (1975)
Cathepsin D: an independent prognostic factor for metastasis of breast cancer.
Frédérique Spyratos;Kamel Hacene;Jacques Rouëssé;Maurice Brunet.
The Lancet (1989)
Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis
Emmanuelle Liaudet-Coopman;Mélanie Beaujouin;Danielle Derocq;Marcel Garcia.
Cancer Letters (2006)
Autocrine Growth Stimulation of the MCF 7 Breast Cancer Cells by the Estrogen-Regulated 52 K Protein
Vignon F;Capony F;Chambon M;Freiss G.
Endocrinology (1986)
In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells.
P. Briozzo;M. Morisset;F. Capony;C. Rougeot.
Cancer Research (1988)
Association between High Concentrations of Mr 52,000 Cathepsin D and Poor Prognosis in Primary Human Breast Cancer
Susan M. Thorpe;Henri Rochefort;Marcel Garcia;Gilles Freiss.
Cancer Research (1989)
The Lancet: saturday 11 November 1989
F. Spyratos;J.-P. Brouillet;A. Defrenne;K. Hacene.
The Lancet (1989)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Institute of Cancer Research of Montpellier
University of Paris-Saclay
Grenoble Alpes University
University of Houston
University of Montpellier
Salk Institute for Biological Studies
Queen Mary University of London
University of Montpellier
Newcastle University
Grenoble Alpes University
University of Ljubljana
Experis
Princeton University
University of Trento
Ulsan National Institute of Science and Technology
Sabancı University
University of Michigan–Ann Arbor
Spanish National Centre for Cardiovascular Research
Nara Institute of Science and Technology
Paracelsus Medical University
New York University
Yamaguchi University
Georgetown University
University of Virginia
University of Tasmania
Fermilab